Irinotecan, Continuous 5-Fluorouracil, and Low dose of Leucovorin (modified FOLFIRI) as First Line of Therapy in Recurrent or Metastatic Colorectal Cancer
Myung-Ah Lee, Jae-Ho Byun, Byoung-Young Shim, In-Sook Woo, Jin-Hyung Kang, Young Seon Hong, Kyung Shik Lee, Myung Gyu Choi, Suk Kyun Chang, Seong Taek Oh, Sung Il Choi, Doo Suk Lee
Korean J Intern Med. 2005;20(3):205-209. Published online 2005 Sep 30 DOI: https://doi.org/10.3904/kjim.2005.20.3.205
Citations to this article as recorded by 
Investigating the therapeutic promise of drug-repurposed-loaded nanocarriers: A pioneering strategy in advancing colorectal cancer treatment
Amina T. Mneimneh, Nadine Darwiche, Mohammed M. Mehanna
International Journal of Pharmaceutics.2024; 664: 124473. CrossRef
Oral delivery of pH-responsive alginate microbeads incorporating folic acid-grafted solid lipid nanoparticles exhibits enhanced targeting effect against colorectal cancer: A dual-targeted approach
Kuldeep Rajpoot, Sunil K. Jain
International Journal of Biological Macromolecules.2020; 151: 830. CrossRef
A Phase I Study of UGT1A1 *28/*6 Genotype-Directed Dosing of Irinotecan (CPT-11) in Korean Patients with Metastatic Colorectal Cancer Receiving FOLFIRI
Kyu-Pyo Kim, Yong Sang Hong, Jae-Lyun Lee, Kyun Seop Bae, Ho-Sook Kim, Jae-Gook Shin, Jung Shin Lee, Tae Won Kim
Oncology.2015; 88(3): 164. CrossRef
Development of Quality Indicators of Care for Patients Undergoing Hepatic Resection for Metastatic Colorectal Cancer Using a Delphi Process
Elijah Dixon, Christopher Armstrong, Guy Maddern, Francis Sutherland, Alan Hemming, Alice Wei, Morris Sherman, Malcolm Moore, Andrew McKay, David Urbach, Martin Labrie, Lee Gordon, Jeffrey Barkun, May Lynn Quan, Scot Dowden, David Bigam, Steven Gallinger
Journal of Surgical Research.2009; 156(1): 32. CrossRef